Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Schreiner MediPharm Announces New Protective Label Feature | Contract Pharma

What are you searching for?

Sign in
Breaking News

Schreiner MediPharm Announces New Protective Label Feature

The update provides dust and dirt protection, and protects from recapping for illegal reuse

By: Betsy Louda

, Contract Pharma

Schreiner MediPharm, a pharmaceutical labeling provider, has introduced new features for its Autoinjector-Labels. They can now incorporate an irreversible first-opening indicator with an anti-recapping functionality, as well as integrated dust protection for particularly challenging applications. 

 

The label will wrap around the autoinjector, including the cap, providing effective dust and dirt protection before the device is initially opened. An integrated perforation clearly indicates that the label has been opened.  This positions it in a way that prevents undetected recapping of the autoinjector for illegal reuse.  

 

Factors in this expansion also include the trend toward self-medication, the increasing incidence of chronic diseases, and a growing biotech sector. 

 

“Our aim is to offer our customers and partners innovative and application-specific solutions which are optimally tailored to their needs, using the latest technologies to enhance product and patient safety.” said Gene Dul, president of Schreiner MediPharm.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters